🔎 Trials Near Me

Home › Trangkaso

Pag-aaral pangklinika para sa Trangkaso na nagre-recruit sa U.S.

47 pag-aaral para sa Trangkaso ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.

Mga lungsod na may pinakamaraming pag-aaral

Ayos sa estado

Mga pag-aaral na kamakailan lamang in-update

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07159763

A Study of Updated mRNA Seasonal Influenza Vaccines

Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 65 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07884175

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07169318

pH1N1 Blinded Challenge Study

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07110532

BPL-1357 Against H1N1 Influenza Virus Challenge

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07215858

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01386424

Systems Investigation of Vaccine Responses in Aging and Frailty

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 21 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT05291676

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 9 hanggang 17 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07870330

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Nagre-recruitPhase 3
28 Days · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT02735707

A Trial to Evaluate the Effect of CD388/MK1406 on the Immunogenicity of Fluzone® HD Vaccine (CD388.SQ.1.08/MK-1406-007)

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 49 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07300085

Age-Associated Differences in Germinal Center Responses to Influenza and Rabies Vaccination in Humans

Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07914673

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07287137

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06160128

Impact of Egg-Based and Cell-Based Vaccine Platforms on Immune Responses to Repeated Influenza Vaccination

Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryoMay bayad para sa mga kalahok
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07910266

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT05624450

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

Nagre-recruitPhase 2
Edad 3 hanggang 17 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05947071

Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07610967

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

Nagre-recruitPhase 3
3 Weeks – 11 Years · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT06094010

High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)

Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07192458

A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT07851246

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT07149428

Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07786467

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 65 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07805707

Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07779408

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT04772170

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.